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Abstract  1 
The physiological functions of natural killer (NK) cells in human immunity and reproduction 2 
depend upon diverse interactions between killer cell immunoglobulin-like receptors (KIR) and 3 
their HLA class I ligands: HLA-A, -B and -C. The genomic regions containing the KIR and HLA 4 
class I genes are unlinked, structurally complex, and highly polymorphic. They are also strongly 5 
associated with a wide spectrum of disease, including infections, autoimmunities, cancers, and 6 
pregnancy disorders, as well as the efficacy of transplantation and other immunotherapies. To 7 
facilitate study of these extraordinary genes, we developed a method that captures, sequences and 8 
analyzes the 13 KIR genes and the HLA-A, -B and -C genes from genomic DNA. We also devised 9 
a bioinformatics pipeline that attributes sequencing reads to specific KIR genes, determines copy 10 
number by read depth, and calls high-resolution genotypes for each of the KIR genes. The method 11 
was validated using DNA from well-characterized cell lines, by comparison with established 12 
methods of HLA and KIR genotyping and by determining KIR genotypes from the 1000 Genomes 13 
Project sequence data. This identified 116 novel KIR alleles, which were all demonstrated 14 
authentic by sequencing them from source DNA using standard methods. Analysis of just two KIR, 15 
showed that 22% of the 1000 Genomes individuals have a novel allele or a structural variant. The 16 
method we describe is suited to the large-scale analyses that are needed for characterizing human 17 
populations and defining the precise HLA and KIR factors associated with disease. The methods 18 
are applicable to other highly polymorphic genes. 19 
 20 
 21 
  22 
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Introduction 1 
The human leukocyte antigen (HLA) complex of chromosome 6 is the most polymorphic region of 2 
the human genome.1 This variation is driven by pressure to resist diverse pathogens, but also 3 
underlies susceptibility to autoimmunity and other inflammatory diseases of major importance to 4 
human health.2 HLA class I molecules are expressed on the surface of most tissue cells, where they 5 
interact with receptors on the surface of lymphocytes, effector cells of the immune system.3 6 
Natural killer (NK) cells are innate and adaptive lymphocytes that destroy infected or tumor cells 7 
having aberrant expression of HLA class I; they also regulate trophoblast invasion during early 8 
pregnancy.4 NK cell activity is genetically modulated through differential expression of 9 
polymorphic killer cell immunoglobulin-like receptors (KIR) that recognize HLA class I 10 
molecules.5 Only recently has the KIR genomic region been characterized to high resolution.6 11 
Consequently, re-examination of diseases having long established associations with specific HLA 12 
polymorphisms is revealing a strong and collective influence from KIR polymorphism.7-10 13 
 14 
The KIR locus of chromosome 19q13.4 is characterized by an unusually high diversity, both in the 15 
numbers of genes and their alleles.11 The region varies in size from 100kbp to 350kbp due to 16 
structurally diverse haplotypes with duplicated segments, large deletions and gene fusions.12; 13 As 17 
a consequence of this plasticity, the 13 distinct KIR genes (MIM: 604936-7, 604945-7, 604952-6, 18 
605305, 610095, 610604) are combined in numerous ways. Haplotypes have between four and 20 19 
KIR genes, with the most common KIR region haplotype having seven genes.14 To varying degrees 20 
each KIR gene is polymorphic, with more than 600 KIR alleles currently defined.15 KIR and HLA 21 
class I (HLA-A, -B and -C: MIM: 142800, 142830 and 142840) polymorphism are actively co-22 
evolving,16 suggesting that many more KIR alleles and haplotypes await discovery. During the last 23 
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three decades over 10,000 HLA class I alleles have been characterized in specialized clinical HLA 1 
laboratories15 and similar intensive study will be needed to characterize KIR diversity.  2 
 3 
The function of an HLA class I molecule is to bind a peptide, usually a nonamer, inside a cell and 4 
take it to the cell surface, where the complex of peptide and HLA class I is engaged by KIR and 5 
other lymphocyte receptors.17; 18 On healthy cells, the peptides bound by HLA class I molecules 6 
derive from normal human proteins and do not stimulate an immune response. On infected or 7 
transformed cell surfaces, pathogen-specific or tumor-specific peptides are bound to HLA class I, 8 
and gross changes in the surface level of HLA class I can be induced. All such differences activate 9 
lymphocytes and the immune response.4; 19 For the interactions of KIR with HLA class I to be 10 
effective they have to respond to a wide diversity of tumors and pathogens, many of which are 11 
rapidly evolving.20 This has been achieved by having a diversity of interactions within each 12 
individual, and differences in those interactions from one individual to another. The latter provides 13 
barriers that can impede the spread of infection within families, communities and populations. 14 
 15 
Crucial features that distinguish KIR and HLA alleles from those of most other genes are the depth, 16 
breadth and functional importance of their sequence divergence. Thus, alleles can differ by 17 
multiple nucleotide substitutions, and three or four alternative nucleotides are present at 18 
functionally critical positions. KIR and HLA alleles segregate as constituents of distinct lineages, 19 
which are further diversified by intra-genic as well as inter-genic recombination.13; 21 In turn, these 20 
lineages are maintained in all human populations and both genomic regions exhibit clear evidence 21 
for the impact of balancing selection.22; 23 Moreover, the strong, highly reproducible signals of 22 
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natural selection observed for the HLA class I and KIR regions point to their genomic variation 1 
being critical for human survival.24; 25 2 
 3 
The development of methods to assess the nature and extent of KIR genomic diversity has been 4 
limited by the complexity of the region. The widely used methods that exist for typing KIR focus 5 
principally on gene content.12; 26-28 In contrast, the methods being used to determine allelic 6 
variation are costly, time-consuming6; 16; 29 and unsuitable for high-throughput studies. The results 7 
of the few allele-level population studies of KIR16; 29-32 however, show that such investigation is 8 
likely to be informative. For example, some KIR are restricted to population groups of specific 9 
geographic ancestry.30; 31 Other KIR have lost expression, but appear common and widely 10 
distributed.29; 32 To extend such studies to other populations, as well as disease cohorts, we have 11 
developed a sequencing and bioinformatics method that determines complete KIR and HLA class I 12 
genomic diversity.  13 
 14 
  15 
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Material and Methods 1 
Overview 2 
To target KIR and HLA class I genes for next generation nucleotide sequencing (NGS), we 3 
designed sets of specific oligonucleotide probes to capture the KIR region (140-240kbp) and the 4 
individual HLA-A, -B and -C genes (each ~3kbp) from libraries prepared from sheared genomic 5 
DNA. We then developed a bioinformatics pipeline (PING: Pushing Immunogenetics to the Next 6 
Generation) specifically to convert sequence data obtained from the highly polymorphic KIR genes 7 
into high-resolution genotypes. A summary of the pipeline is shown in Figure 1A. PING first sorts 8 
the sequence reads to isolate those that represent fragments from the KIR genomic region from 9 
those that do not (a process termed filtering). The final KIR genotypes are obtained from these 10 
filtered reads, using a composite of two core modules that describe the gene and allele content for 11 
each individual and also return information on newly-identified SNPs and recombinant alleles. The 12 
first module (PING_gc), which determines the KIR gene copy-number, is used to inform the 13 
second module (PING_allele) that generates allele data (Figure 1A and Figure S1). Each module is 14 
split into two sub modules. KIR Filter Fish (KFF), which is used in both main modules, probes the 15 
KIR sequence data with specific sequence search strings and determines which genes (KFFgc) or 16 
alleles (KFFallele) are present. The function served by KFF is equivalent to genotyping with 17 
sequence-specific oligonucleotide probes (SSOP).33 To complement KFF, MIRAgc (based around 18 
the program MIRA)34 and Son of Samtools (SOS; based around Samtools)35 create alignments to 19 
reference sequences in order to determine the gene and allele content, respectively. The output is 20 
designed to comply with the genotype list (GL string) format that is used for reporting HLA and 21 
KIR data by clinical transplantation laboratories.36 We validated the typing obtained from the 22 
complete capture/NGS and bioinformatics method by using standard molecular techniques, and 23 
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further tested the bioinformatics component using existing data sets from whole-genome 1 
sequencing experiments. A summary of the data generated or otherwise obtained is shown in 2 
Figure 1B. KIR and HLA class I allele sequences used for probe design and as reference data were 3 
obtained from the ImmunoPolymorphism Database (IPD; see Web Resources).15 Throughout this 4 
paper any unique DNA sequence that spans a coding region (coding DNA sequence: CDS) is 5 
considered a distinct allele. An explanation of KIR and HLA nomenclature is given in Appendix 6 
A. 7 
 8 
Human Subjects and Data 9 
Ethical approval for this study was obtained from the Stanford University Administrative Panels 10 
on Laboratory Care and Human Subjects in Medical Research and The Committee on Human 11 
Research at the University of California, San Francisco. Written informed consent was obtained 12 
from all individuals. 13 
 14 
To develop and validate the complete capture/NGS and bioinformatics method we generated data 15 
from three sources of human genomic DNA:  16 
 17 
1. A panel of IHWG lymphoblastoid B cell lines. 18 
Genomic DNA was extracted from 97 International Histocompatibility Working Group (IHWG) 19 
cell lines. These cells have been used extensively in developing methods for genotyping 20 
polymorphic loci including KIR and HLA.37-41 Most of the cell lines (93%) are homozygous for the 21 
HLA-A, -B, and -C genes.37-41 A substantial majority of the IHWG cells (80%) are derived from 22 
donors of European origin and represent many of the common HLA alleles.42; 43 Also studied was 23 
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genomic DNA from a chimpanzee B cell line, derived from Clint44 (Yerkes pedigree number 1 
C0471), a chimpanzee of the Pan troglodytes verus (western chimpanzee) subspecies, and subject 2 
of the Chimpanzee Genome sequence study.44 3 
 4 
2. West African Trios 5 
Genomic DNA samples from 30 family trios (both of the parents and one child) from Mali in West 6 
Africa were analyzed.45  7 
 8 
3. European control samples 9 
De-identified DNA samples from 188 unrelated healthy individuals of European origin, with no 10 
history of chronic disease, were studied. These samples were selected at random from a larger data 11 
set (n=500) developed as controls for genome wide association studies of multiple sclerosis (MS 12 
[MIM: 126200]).46 These samples were used because their high-resolution HLA-A, -B, and -C 13 
genotypes had been determined using Sanger sequencing.46  14 
 15 
4-5. Analysis of existing NGS data 16 
To validate the PING pipeline, we used existing sequence read data from an additional two 17 
sources, described below under 4 and 5. To extract KIR specific sequences from these data sets, 18 
read-pairs that mapped within the KIR region (hg19 coordinates: 19:55,228,188-55,383,188) or an 19 
unallocated region of chromosome 19 (GL000209.1) that corresponds to an alternative KIR 20 
haplotype were identified using SAMtools 0.1.18.35 21 
 22 
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4. Fifteen KhoeSan individuals,47 who had also been KIR genotyped using standard lower 1 
throughput methods of pyrosequencing and Sanger sequencing.16  2 
 3 
5. The 1000 genomes project data.48 All 2,532 of the whole-exome sequenced individuals 4 
described in the May 2013 release were targeted.48 To ensure sufficient quantity of sequence reads 5 
for the analysis, samples were excluded if there were fewer than 25 reads that map to exon 3 of 6 
KIR3DL2 or KIR3DL1/2v (See Appendix A: KIR and HLA nomenclature). There were 420 of the 7 
1000 genomes samples excluded on this basis and the remaining 2,112 were genotyped. When 8 
novel KIR alleles were identified in the 1000 genomes data set, genomic DNA from the source 9 
samples was purchased from the Coriell repository for confirmation of their sequence using 10 
standard molecular methods. 11 
 12 
Laboratory Methods 13 
Design of capture oligonucleotide probes 14 
To account for gene content variation of the KIR region, we targeted a panel of independently 15 
generated reference KIR haplotypes,6; 14 that together represent all of the 13 recognized KIR genes. 16 
First we designed probes against the two complete KIR haplotypes (FP089703 and FP089704) that 17 
were generated from the PGF cell line, which was the source of the human reference sequence for 18 
the KIR region.6 We used end-to-end tiling, with strand-swapping, to design non-overlapping 80-19 
mer probes to match these reference sequences. We then designed a similar set of probes using a 20 
further 27 complete KIR haplotype sequences6; 14 and all KIR sequences included in the January 21 
2013 release of the IPD/KIR database.15 In this second stage, probes that differed by more than 22 
three nucleotides from the corresponding segment of the initial reference haplotypes were selected 23 
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for use. We did not mask any repetitive elements in the target haplotypes. The KIR genomic region 1 
targeted by the probes is equivalent to that covered by (hg19) chr19:55,228,188-55,383,188 and 2 
chr19: unmapped GL000209.1, which are the two KIR haplotypes present in the hg19 reference 3 
genome. In a similar manner to the KIR probes, we designed probes against the alleles of the 4 
classical HLA class I genes present in PGF, which was also the source of the human reference 5 
sequence for the HLA region.1; 14 These probes were supplemented with probes designed against 6 
the 6,795 HLA class I sequences reported in the January 2013 release of the IPD/HLA database.15 7 
A total of 10,456 capture probes were used.  8 
 9 
Preparation of biotinylated capture probes.  10 
The set of capture oligonucleotides, each one comprising a unique sequence flanked by the 11 
common sequences, GGTGATTGCGTATCT (PTL3) and CATGTCGTGGGAATT (PTR3), was 12 
synthesized by CustomArray (Bothell, WA). This set of oligonucleotides was pooled and 13 
amplified in a single PCR, using primers with sequences corresponding to PTL3 and PTR3. The 14 
PCR comprised 1x Titanium Taq buffer (Clontech, Mountain View, CA), 1uM each of biotin-15 
PTL3 and PTR3 primers (Integrated DNA Technologies (IDT), Coralville, IA), 0.2 uM dNTPs 16 
with 12.5% dUTP (Roche, Indianapolis, IN), 1ul (1 unit) Uracil-DNA Glycosylase (UDG; New 17 
England Biolabs), 1M betaine, 3ul (15 units) Amplitherm polymerase (Epicentre, Madison, WI), 18 
0.2 ng of the pool of capture oligonucleotides and H2O added to a final volume of 100ul. PCR 19 
cycling conditions were as follows: 37oC (10 min), 95 oC (3 min), (95oC (30 s), 55oC (30 s), 72oC 20 
(30 s) x 28), 72oC (10 min.), and 10oC (hold).  21 
 22 
11 
 
The biotinylated PCR product (100ul aliquot) was then bound to streptavidin-coated magnetic 1 
beads (Illumina, Inc) that had been pre-washed with 100ul 6x Hybridization Buffer (HB:1 M 2 
NaCl, 0.5M phosphate buffer, 0.05% Tween-20) and suspended in 100ul 12x HB. The incubation 3 
was carried out for 30 min at room temperature in HB and with agitation. The beads, now coated 4 
with biotinylated oligonucleotides, were then washed: once with 100ul 6x HB, twice with 100ul 5 
0.2x HB, once with 100ul 0.1nM NaOH and 100ul 10 mM EDTA, and, lastly, once with 100ul 6 
0.2x HB. Biotinylated oligonucleotides were eluted from the beads using 0.1 mM EDTA, then 7 
concentrated using speed vacuum to a final concentration of 2.5nM for each capture probe.  8 
 9 
Library preparation, enrichment and sequencing 10 
The protocol was based on the Truseq Nano method for library preparation (Illumina Inc., San 11 
Diego, CA). The DNA samples we used are described below. For each sample, 300ng genomic 12 
DNA (as determined by Qubit instrument: ThermoFisher, Sunnyvale, CA) were sheared into 13 
800bp fragments using a Covaris S220 instrument (Covaris, Woburn, MA). The library preparation 14 
was then performed according to the manufacturer’s instructions, with 96 unique ‘dual index’ 15 
combinations used individually to label the library obtained from each DNA sample, and the 16 
following modifications: 1. To clean/size-select the samples following end-repair, 70.2ul sample 17 
purification beads plus 89.8ul H20 were added to 100ul sample. 2. In the final PCR the 72
oC 18 
extension time was changed from 30s to 90s to account for the 800bp fragment length.  19 
 20 
Enrichment for HLA/KIR region sequences was performed using a modified version of the Nextera 21 
Rapid Capture Exome enrichment protocol (Illumina Inc., San Diego, CA), a solution-based target 22 
capture assay. The libraries of genomic DNA, indexed uniquely for each sample as described 23 
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above, were pooled prior to their hybridization with the capture probes. Thus, each hybridization 1 
mix (100ul) contained 96 uniquely indexed sequence libraries (62.5ng for each library: 6000ng in 2 
total), 50 pM of each biotinylated capture probe and hybridization buffer (CT3, and all subsequent 3 
buffers from Illumina Inc., San Diego, CA). The hybridization mix was incubated at 95oC for 10 4 
mins, gradually cooled by 2oC per minute to 58oC then maintained at 58oC for 90 mins. In this 5 
reaction, fragments of genomic DNA that contained targeted KIR and HLA sequences became 6 
specifically hybridized to biotinylated capture probes. 7 
 8 
In the next reaction, 100ul of streptavidin-coated magnetic beads were used to separate the specific 9 
hybridized genomic DNA away from the non-specific un-hybridized genomic DNA. The biotin 10 
present in hybrid DNA molecules was bound to streptavidin on the beads, leaving the non-specific 11 
DNA in solution. The DNA preparation enriched for the targeted KIR and HLA genes was then 12 
eluted from the beads. Binding of the hybridization product to the beads was achieved by 30 min 13 
incubation with agitation at 1000rpm on a plate shaker at room temperature. To clean the product, 14 
the streptavidin beads were removed from solution using a magnetic separator, mixed with 200ul 15 
Enrichment Wash Solution (Illumina Inc., San Diego, CA), and incubated at 50oC for 30 minutes. 16 
This wash step was repeated. To elute the enriched DNA from the beads we added 23ul of elution 17 
mix (made from 1.5ul 2M NaOH plus 28ul Elution Buffer 1), incubated for 5 minutes at room 18 
temperature and neutralized with 4ul Elute Target Buffer 2. The eluted material was then subject to 19 
a second round of enrichment from the hybridization step onwards. After the gradual cooling step, 20 
the hybridization mix was maintained at 58oC for 14-18 hours. 21 
  22 
 23 
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An aliquot of 10ul of the enriched DNA preparation was subject to PCR amplification in a 50ul 1 
reaction mix containing 5ul of PCR Primer Cocktail and 20ul of Nextera Enrichment 2 
Amplification Mix PCR cycling was performed as follows: 98oC for 30s, 17 cycles of 98oC for 3 
10s, 60oC for 30s, and 72oC for 30s with a final elongation step at 72oC for 5 min. Amplified 4 
material was purified with 40ul of Sample Purification Beads and eluted in 30ul of RSB (Illumina 5 
Inc. San Diego, CA).  6 
 7 
NGS strategies 8 
Set 1. (IHWG cell lines) The enriched libraries were sequenced using a HiSeq2000 instrument and 9 
sequencing chemistry (Illumina Inc., San Diego, CA). Samples were clustered and paired-end 10 
sequencing performed with the TruSeq SBSv3-HS kit (Illumina Inc., San Diego, CA). The 11 
sequencing read length was 2 x 101bp. 12 
 13 
Set 2. (Trios and chimpanzee). The enriched libraries obtained from these samples were sequenced 14 
using a HiSeq2500 instrument and sequencing chemistry (Illumina Inc., San Diego, CA). The 15 
sequencing read length was 2 x 250bp. These samples were also genotyped for HLA-A, -B and -C 16 
using SSOP, and Lineage II KIR using pyrosequencing23 (See Appendix A: KIR and HLA 17 
nomenclature). 18 
 19 
Set 3. (European controls) These samples were analyzed using a MiSeq instrument (Illumina Inc., 20 
San Diego, CA) with V3 chemistry and the sequencing read length was 2 x 300bp.  21 
 22 
Enrichment efficiency  23 
14 
 
Enrichment efficiency was estimated by mapping unprocessed sequence reads to the human 1 
reference (hg19) using BWA-MEM49 (with k=16) and counting the number of reads that map 2 
within the target coordinates of hg19.  3 
 4 
Validation of the results from capture/NGS using established methods 5 
Previously described protocols were used for pyrosequencing16 and real-time PCR.12 Standard 6 
Sanger DNA sequencing reactions were performed in forward and reverse directions using BigDye 7 
Terminator v3.1 and analyzed using an ABI-3730 sequencer (ABI, Foster City CA). To verify the 8 
sequences of novel alleles, PCR products were cloned using the pCR2.1-TOPO vector (Invitrogen, 9 
Carlsbad, CA) and sequenced using M13 and internal primers. For each individual in whom an 10 
allele was identified for the first time, five or more clones corresponding to the allele were 11 
sequenced. HLA class I genotyping was performed using Luminex bead-based SSOP hybridization 12 
as described previously16 except where indicated otherwise. 13 
 14 
Bioinformatics methods: Pushing Immunogenetics to the Next Generation (PING) pipeline 15 
Harvesting KIR specific reads 16 
For sequence data obtained by the capture/NGS sequencing method, sequence reads specific to the 17 
KIR region were identified and harvested using Bowtie 2.50 The 29 sequenced KIR haplotypes and 18 
all KIR alleles from the IPD/KIR database6; 14; 15 were concatenated to create a single reference file 19 
for this purpose. The equivalent of 70,000 reads (at 2 x 300 bp) that passed this filter stage were 20 
taken per sample for KIR genotyping. 21 
 22 
KIR gene-content module (PING_gc) 23 
15 
 
This module is divided into two complementary components, the first (KFFgc) based on string 1 
searches of raw data and the second (MIRAgc) on read-depth following alignment to reference 2 
sequences.  3 
 4 
1. KIR gene-content determination by virtual probes (KFFgc) 5 
The sequence read files specific to the KIR region were first processed using the ‘fastq quality 6 
trimmer’ function of Fastx Toolkit 0.0.13 (see Web Resources). From an alignment of all human 7 
KIR sequences (IPD/KIR Release 2.6.1, 17 February 2015),15 all possible 32bp sequences specific 8 
to just one of the KIR genes were generated, and those sequences covering polymorphic positions 9 
removed. For each KIR gene, this process produced a set of probes that is gene-specific but not 10 
allele-specific. For each gene, ten such probes were selected at random and used for determining 11 
KIR gene-content. We then counted the total number of exact matches to each probe sequence, and 12 
its reverse complement, present in the forward and reverse (read1.fastq and read2.fastq) sequence 13 
read files for each sample. As every KIR haplotype has one copy of KIR3DL3,6; 14; 16 the 14 
presence/absence of other KIR genes was determined from the mean number of probe-hits per 15 
target KIR divided by the mean number of KIR3DL3 probe-hits on KIR3DL3. We used a ratio of 16 
0.2 as the threshold, and values above this were considered positive.  17 
 18 
2. KIR gene copy number determination by analysis of read depth (MIRAgc) 19 
As shown previously, the depth of reads aligned to a reference can be used to estimate structural 20 
variation on a genomic scale.51; 52 We incorporated this concept into the KIR genotyping pipeline. 21 
Using MIRA 4.0.234, the KIR region specific sequence read pairs were aligned simultaneously 22 
against one reference sequence for each KIR gene. Using values extracted from the ‘contigstats’ 23 
16 
 
results table from the MIRA output, the number of reads that align to each KIR gene were divided 1 
by the number of reads aligning to KIR3DL3. This comparison produced a clustering of read ratios 2 
that correlates with differences in KIR gene content (Figure 2 and Figure S2). For example, for 3 
KIR2DL4, which is absent from some haplotypes and duplicated on others,13; 53 we observed three 4 
clusters of read ratios, corresponding to one, two or three copies of KIR2DL4 (Figure 2). For 5 
KIR2DL5, which can be present at centromeric and telomeric locations in the KIR haplotype,6; 54 6 
we observed five clusters of read ratios, corresponding to individuals having zero, one, two, three 7 
or four copies of KIR2DL5 (Figure 2). Representative examples of clustering results derived for all 8 
the KIR are given in Figure S2. 9 
 10 
In very rare cases there may be copy number variation of KIR3DL3. For example, an individual 11 
with duplicated KIR3DL3 on one haplotype was observed in a study of >3,500 subjects.12 Such 12 
individuals would then show an unusual copy number for all of the KIR genes, and hence would be 13 
identified for manual inspection. The individual identified with a duplicated KIR3DL3 had a 14 
normal genotype of two KIR3DL2 copies,12 so in this case KIR3DL2 could be used as a substitute 15 
standard. 16 
 17 
KIR allele genotyping module (PING_allele). 18 
This module is also divided into two complementary components, the first (KFFallele) based on 19 
string searches of raw data and the second (SOS) on read-depth following alignment to reference 20 
sequences. A summary of the KFFallele workflow is shown in Figure S1A, and SOS in Figure 21 
S1B and Figure S1C. 22 
 23 
17 
 
1. High-resolution KIR genotyping with virtual probes (KFFallele) 1 
For each KIR gene, an alignment of coding region alleles was generated. From these, every 2 
possible unique 32-mer sequence that did not overlap an exon boundary was generated and the 3 
resulting pool screened to remove all 32-mers that are present in another KIR gene. A ‘hit table’ 4 
was generated using the original allele alignment and bespoke R scripting 5 
(allgenos_hit_table_2.R). The hit table was passed on to a random forest algorithm using the 6 
‘RandomForest’ package of the R computer program suite.55 This algorithm ranks the probes 7 
according to the amount of information they contribute to the final answer. The purpose of the 8 
random-forest step is to obtain the most efficient subset of probes, thereby increasing the 9 
computational speed of genotype assignment. The output consists of a series of probe subsets that 10 
have an increasing proportion of the total set (5%, 10%, 15% …etc.). Empirical testing found the 11 
most efficient subset is usually the 40% most informative probes. The final probe subset was 12 
applied to the original allele alignment, to produce a hit table of the expected probe pattern for all 13 
possible genotypes (again using allgenos_hit_table_2.R). The number of exact matches to each 14 
probe sequence, or its reverse complement present in the forward and reverse files (read1.fastq and 15 
read2.fastq) for each sample, was then counted. Aggregate counts above a threshold of 10 were 16 
considered positive, and the results compared with the genotype ‘hit table’ using a bespoke R 17 
script (KFFsums.R) to assign the KIR allele genotype.  18 
 19 
2. KIR sequence alignment genotype by SOS 20 
Data used to generate filters and reference sequences were obtained from the IPD/KIR database 21 
(Release 2.6.1, 17 February 2015) and the set of 29 complete KIR haplotype sequences.6; 14; 15 For 22 
each given KIR gene, all available allele sequences were selected for use as a positive filter and all 23 
18 
 
allele sequences of all other KIR genes were used to form a negative filter. Sequence reads specific 1 
to the given KIR were selected by mapping them to the positive filter, using Bowtie 2.50 This 2 
mapping was performed non-stringently (>=97% nucleotides match) to allow for detection of 3 
unknown SNPs. All reads that aligned to the positive filter were retained, and those that did not 4 
were excluded. The retained reads were mapped stringently (>=99% match) to the negative filter, 5 
and in this case those that aligned were excluded. Finally, the selected reads were aligned to a 6 
single reference sequence, chosen for each KIR (Figure S3), and the SNP variants ascertained 7 
using SAMtools/bcf version 1.2.35; 50  8 
 9 
The resulting variant call files (vcf) were analyzed using a custom R script (jSOS) to generate 10 
genotypes based on the known combinations of SNPs (i.e. the unique KIR alleles available from 11 
IPD). A post-filtered and aligned read depth of 20 was used as the minimum for calling the 12 
genotype at any given nucleotide position. The jSOS algorithm determines all of the possible allele 13 
combinations based on the genotypes of those SNPs that achieve the threshold read depth. Thus, if 14 
a specific SNP fails to reach the threshold, the ambiguity of the final allele call will increase, but 15 
an incorrect allele-level genotype will not be returned. When the combination of SNPs does not 16 
correspond to a known pair of alleles, jSOS identifies that a novel combination of known SNPs is 17 
present. In these situations, the known allele most likely present is identified as well as the new 18 
combination (we view this as the most parsimonious genotype, and the least parsimonious could be 19 
two novel combinations present). The jSOS algorithm also identifies novel SNPs. When manual 20 
confirmation was sought, such as these cases of novel polymorphism, alignments for visual 21 
inspection were created using MIRA 4.0.2, and examined using Gap4 of the Staden package.56 22 
 23 
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HLA class I genotypes 1 
The HLA class I allele compositions were determined using NGSengine 1.7.0 (GenDX software, 2 
Utrecht, NL), kindly provided by Wietse Mulder and Erik Rozemuller, with the ‘IMGT 3.18.0 3 
combined’ reference set. There was no pre-filtering for HLA genes and the data was analyzed 4 
directly with the software. The one exception was the removal of reads mapping to HLA-Y, an 5 
HLA class I pseudogene present on a subset of HLA haplotypes.57 Presence or absence of HLA-Y 6 
was determined using sequence specific string searches of the fastq data. For the IHWG cells these 7 
assignments agreed with those previously determined using PCR.43 The assignment of HLA class I 8 
alleles was further validated by analyzing the sequence data with Assign MPS 1.0 (Conexio 9 
Genomics, Fremantle Australia), kindly provided by Damian Goodridge. Any discrepancies 10 
between the two methods, or with previously obtained results, were resolved by designing virtual 11 
probes that distinguish the two possibilities in question and searching the unprocessed sequence 12 
read data (as described for KFF). Then sequence reads specific to the locus under question were 13 
extracted and aligned to reference sequences (as described for SOS) and inspected manually. Here, 14 
the reference sequences used were chosen based on the HLA class I genotype of the respective 15 
sample. The majority of HLA class I alleles are not fully characterized through all exons and 16 
introns (>95%)15. Thus for some of the validations, the second or third fields of resolution were 17 
compared. 18 
 19 
Haplotype assignments 20 
Haplotypes derived from homozygous cell lines were unambiguous. Haplotypes were assigned for 21 
the family trios by segregation. For all other individuals, centromeric and telomeric allele-level 22 
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KIR haplotypes were assigned for each individual using the expectation–maximization (EM) 1 
algorithm of haplo.stats implemented in the R programming language (see Web Resources). 2 
 3 
  4 
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Results 1 
Validation of the KIR capture method 2 
We applied our capture/NGS method to DNA extracted from 97 publically available cell lines 3 
(sample Set 1; Material and Methods), originally collected by the IHWG to facilitate study of HLA 4 
genes.40 PGF is one of these cell lines having both KIR haplotypes characterized previously by 5 
standard methods.6; 14 Data we obtained from PGF were therefore used to assess the quality of KIR 6 
sequences produced. The PGF KIR sequence reads were mapped back onto the two conventionally 7 
determined haplotype sequences. For PGF KIR haplotype 1 (FP089703: 137,813bp), our method 8 
gave 100% coverage, a mean read depth of 49.4x and a read depth of >10x for 99.5% of the 9 
haplotype (Figure 3A-B). For PGF KIR haplotype 2 (FP089704: 142,732bp), we obtained 99.99% 10 
coverage, a mean read depth of 49.8x and a read depth >10x for 99.5% of the haplotype. There are 11 
two short gaps in our haplotype 2 sequence, comprising 18 nucleotides in total (Figure 3C). The 12 
missing sequences are not predicted to be of functional importance (Figure 3C). Thus our method 13 
gives full coverage of the KIR region when targeting haplotypes that were among those included in 14 
the probe design. However, for population studies it is important that our probe sets can cope with 15 
a wider (and unknown) range of diversity, with no ‘allelic dropout’. As a test, we applied our 16 
method to genomic DNA from the subject of the chimpanzee genome project.44 We mapped the 17 
reads obtained to the two full KIR haplotype sequences (BX842589 and AC155174) that were 18 
previously characterized from this individual.25; 58 These sequences represent both haplotypes of 19 
the KIR region and include ten of the fourteen chimpanzee KIR genes. We obtained 98.8% 20 
coverage for both of the haplotypes, with mean read depth of 130x for haplotype 1 and 110x 21 
haplotype 2. This success in capturing the chimpanzee KIR region strongly indicates that our 22 
method captures the full range of human KIR haplotypes. 23 
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 1 
Efficiency of the KIR capture method 2 
To estimate the efficiency of the capture process we mapped all sequence reads generated for each 3 
individual back to the human genome, and counted those that fell within the target coordinates. 4 
Using this measure, the mean enrichment efficiency of the optimized 2 x 300bp sequencing runs 5 
(sample Set 3) was 87.01% (sd 5.01). Because the target region represents <0.01% of the human 6 
genome, this represents a significant (10,000 x) reduction in sequencing capacity required to 7 
analyze the target, compared with whole genome sequencing. 8 
 9 
Specificity of sequence read harvesting 10 
To begin the bioinformatics analysis of KIR we use a panel reference haplotype sequences as 11 
filters to harvest from the main pool of sequenced fragments, any sequence reads that could map to 12 
the KIR region (described in Material and Methods). As both the capture probes and the reference 13 
sequences for harvesting reads were designed using complete KIR haplotypes that did not have 14 
repetitive elements masked, we performed a further test for specificity on the harvested KIR reads. 15 
By analyzing 70,000 of these read pairs per individual, we showed a mean of three read pairs 16 
(modal value = 0) could map outside the target region of human genome build hg19. Thus, the 17 
combination of capture/NGS method and KIR sequence read harvesting is highly-specific. We also 18 
note that when we generated 2 X 100 bp sequence reads (instead of 2 X 300), up to 12% of the 19 
harvested reads potentially originate from repetitive elements outside the KIR region. However, 20 
100% of these reads map to a 1.8kb LINE insertion that is located in intron 6 of KIR3DL213 21 
(Figure S4) and does not overlap with any known control elements. Thus these reads do not affect 22 
the subsequent analysis.  23 
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 1 
Measurement of KIR gene copy number (PING_gc) 2 
The PING_gc component of PING specifically determines gene copy number. KIR3DL3, a single-3 
copy gene common to all KIR haplotypes6; 14; 16 is used as the standard to which other KIR genes 4 
are compared (Material and Methods). To assess the correlation between read ratio and KIR gene 5 
content, we applied PING_gc to the sequence data generated from the 97 IHWG samples. In using 6 
the first module of PING_gc (called KFFgc) we observed identical results to those obtained by 7 
established methods,26; 59; 60 producing thirteen distinct KIR gene presence/absence genotypes 8 
(Figure 4A). We then applied the second module of PING, MIRAgc, and used the observed 9 
clustering (Figure 2) to set threshold values for determining KIR gene copy numbers (Figure S3). 10 
To validate these results, DNA samples from 85 of the same cell lines were studied using an 11 
established real-time PCR method for quantifying KIR genes.12 We observed 99.4% concordance 12 
between the results obtained by PING_gc and those obtained by the real-time PCR (Figure 4B). Of 13 
10 discordant results, from 1,700 determinations, four involve rare alleles that were not detected by 14 
the primers of the real-time PCR assay (KIR2DL2*009 and KIR3DL2*076; the latter allele being 15 
discovered during this study). Of the other six discordant results, two were due to false positives of 16 
the real-time PCR (as shown independently using a standard PCR method)27, two were just below 17 
the threshold values of the real-time PCR (but clearly positive with PING_gc and standard PCR) 18 
and two remain unexplained (Figure 4B). Thus, the discrepancies were likely due to low-frequency 19 
errors in sensitivity or specificity of the real-time PCR method. We conclude that analysis of high-20 
throughput sequencing data with the PING_gc module provides precise measurement of KIR gene 21 
content and copy number, giving almost 100% accuracy. Using PING_gc, we identified 26 distinct 22 
KIR gene copy number genotypes in the 97 cell lines analyzed (Figure 4C). Two cells have 23 
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duplicated KIR3DP1-2DL4-3DL1/S1 segments (Copy number genotypes 10 and 18; Figure 4C) 1 
and three cells have haplotypes lacking KIR2DL4 (genotypes 12, 13 and 15; Figure 4C). In 2 
summary, determination of copy number alone increases the resolution of KIR genotyping and is 3 
an important step towards understanding the role of KIR polymorphism in disease.61 We next 4 
sought to include the allele calling components in validation of the PING pipeline in order to 5 
achieve full resolution of KIR genotypes. 6 
 7 
High resolution genotypes of KIR alleles (PING_allele) 8 
PING_allele determines KIR allele genotypes according to all known KIR coding sequence alleles 9 
(Material and Methods). PING_allele was first validated using whole-exome data from a sample of 10 
15 KhoeSan individuals.47 For these individuals, the KIR copy number and allele data produced by 11 
PING matched the data obtained previously using the established methods of Sanger sequencing 12 
and pyrosequencing-based genotyping of KIR genes.16; 31 Because the KIR3DL1, KIR3DS1 and 13 
KIR3DL2 genes of lineage II KIR (See Appendix A: KIR and HLA nomenclature) exhibit high 14 
polymorphism and structural variation,13; 23; 62 they were chosen as a further test of PING_allele. 15 
The pipeline was applied to data obtained, using the capture/NGS method, from 30 family trios 16 
from Mali in West Africa (sample Set 2; Material and Methods). In this highly heterozygous 17 
population we identified 18 KIR3DL1/S1, 15 KIR3DL2 alleles and three KIR3DL1/2v alleles 18 
(Figure S5A). These alleles were authenticated using established pyrosequencing and Sanger 19 
sequencing methods (Material and Methods), as well as by their segregation in the trios. 20 
KIR3DL1/2v is a fusion of KIR3DL1 and KIR3DL2 that segregates with KIR3DL1/S1 and 21 
expresses a functional protein.13 Importantly, we correctly identified individuals having distinct 22 
combinations of KIR3DL1/S1 alleles, KIR3DL1/2v fusion genes and KIR3DL1-deleted haplotypes 23 
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(Figure 5). To expand the analysis, we next analyzed 2,112 individuals of the 1000 genomes data 1 
set.48 From their exome sequences, we identified 50 KIR3DL1/S1, 46 KIR3DL2 and five 2 
KIR3DL1/2v alleles (Figure S5A), as well as 14 KIR3DL1/S1 duplication and 13 KIR3DL1/S1 3 
deletion haplotypes (Figure S5B). Such duplicated and deleted KIR haplotypes were detected in all 4 
26 populations represented in the 1000 genomes dataset (Figure S5B). These results demonstrate 5 
that the capture/NGS method coupled with the copy number and allele components of the PING 6 
pipeline correctly identify the extensive and complex variation of lineage II KIR. The KIR3DL1/S1 7 
and KIR3DL2 genotypes obtained for all individuals analyzed from the 1000 Genomes project are 8 
shown in Figure S5C. 9 
 10 
Novel Allele Identification by PING 11 
We describe KIR variants that were previously undiscovered, but identified and characterized 12 
using the methods described here, as ‘novel’. The PING pipeline identifies such novel alleles by 13 
the presence either of one or more novel SNPs or a novel combination of known SNPs (Material 14 
and Methods). To test this ‘new allele discovery’ component of PING we again used the lineage II 15 
KIR genes. In the course of analyzing the 1000 Genomes data, we identified 100 novel alleles: 33 16 
KIR3DL1/S1, 65 KIR3DL2, and two forms of KIR3DL1/2v. Defining these alleles are 88 novel 17 
SNPs (39 in KIR3DL1/S1, 49 in KIR3DL2: Figure S6A and Figure S6B) and 17 novel 18 
combinations of known SNPs (Figure S6C). Sequences for all the novel alleles were validated by 19 
standard methods: PCR amplification from genomic DNA of source material, followed by cloning 20 
and/or Sanger sequencing (Material and Methods). Of the 2,112 individuals studied, 229 (10.8%) 21 
have at least one novel lineage II KIR allele (Figure S5C). A total of 333 different KIR3DL1/S1-22 
KIR3DL2 haplotypes were identified in this analysis (Figure S5C).  23 
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 1 
High resolution allele and copy number KIR genotypes 2 
We applied PING_allele to the KIR sequence data obtained from the 97 IHWG cells. This analysis 3 
of 13 KIR genes identified 144 different KIR sequences, 128 corresponding to established alleles 4 
and 16 representing novel alleles. The latter were all shown to be authentic using the standard 5 
methods described above for KIR3DL1/S1 and KIR3DL2 (Figure S6D). By considering all 144 6 
KIR variants, we identified a minimum of 104 centromeric and 42 telomeric KIR haplotypes in the 7 
cell panel (Figure 6 and Figure S7). Consistent with our results are KIR genotyping data obtained 8 
previously from the IHWG cells, which achieved a limited discrimination of alleles.6; 59 These 9 
analyses demonstrate that PING accurately processes high-throughput sequence data to give 10 
accurate high-resolution KIR genotypes. The high-resolution KIR genotypes of the IHWG cell 11 
panel has been compiled (Figure S7), providing a resource for future investigation. 12 
 13 
Validation of the high-resolution HLA class I capture method 14 
Because KIR and HLA class I glycoproteins are functionally interacting receptors and ligands, the 15 
capture/NGS method was designed to capture and analyze the two gene families in the same 16 
reaction (Material and Methods). To validate the HLA class I sequences obtained by this method, 17 
we first analyzed the panel of 97 IHWG cell lines. In previous studies38-40, including high-density 18 
whole genome SNP analysis,43 90 of the IHGW cells were judged to be homozygous for HLA-A, B 19 
and C, with five of the other seven cells being homozygous for two of the three HLA class I genes. 20 
Our high-throughput sequencing results are completely concordant with the genotypes previously 21 
determined by conventional methods15 (Figure S8A). In the course of validation, we defined two 22 
novel HLA-C alleles that encode distinctive proteins (Figure S8B). Because our method gives full-23 
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length genomic sequences, including intron and flanking region sequences, all the HLA -A, -B, -C 1 
alleles of the IHWG cells are now defined at much higher resolution (“four field” see Appendix A: 2 
KIR and HLA nomenclature) than previously achieved. 3 
 4 
The IHWG cells represent an unusual, and highly selected, sampling of the human population 5 
because they are HLA homozygous, and many of them derive from consanguineous individuals. To 6 
extend the study to heterozygous individuals, we applied the capture/NGS method to 30 West 7 
African family trios from Mali (sample Set 2; Material and Methods) and 188 individuals selected 8 
at random from a panel of healthy Europeans (sample Set 3). The capture/NGS method achieved 9 
full coverage of the HLA class I genes, and an example of the result obtained from one individual 10 
is shown in Figure 7A. In the Africans, 22 HLA-A, 30 HLA-B and 15 HLA-C alleles were 11 
identified. These allele sequences agreed completely with HLA class I genotypes we determined 12 
using standard probe-based and Sanger sequencing methods. They were also consistent with the 13 
observed segregation of HLA -A, -B, -C alleles within the family trios (Figure S8C-D). In total, 170 14 
distinct HLA class I alleles were identified in the three validation sets (IHWG cell lines, African 15 
trios and the Europeans). These 170 alleles, include 62 of the 69 fundamental allele types defined 16 
by the first two digits of the HLA nomenclature (Figure 7B), and thus cover most, if not all, of the 17 
breadth of HLA class I allelic diversity.21 Thus it is likely that all HLA-A, -B and -C alleles can be 18 
captured and sequenced by our method. In support of this thesis, the capture/NGS method robustly 19 
detects and sequences B*73:01 (Ashouri et al. in prep), a unique allele of archaic origin that has by 20 
far the most divergent HLA class I gene sequence in the modern human population.63 Further 21 
demonstrating our method’s robust capacity to target divergent sequences, we successfully 22 
captured and sequenced all alleles of the Patr-A, -B, -C genes (Figure S8E), the orthologs of HLA-23 
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A -B -C, respectively, from the chimpanzee that was the subject for the chimpanzee genome 1 
project.44 In summation, the breadth and depth of our results give confidence that our method will 2 
be able to capture the full range of HLA class I alleles.  3 
 4 
  5 
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Discussion 1 
We developed an integrated capture/NGS and bioinformatics method to characterize completely 2 
the structure and sequence of the highly polymorphic KIR and HLA class I genes. The approach 3 
enables a focused and extensive definition of this physiologically important variation, which is not 4 
possible with any other single method. Our method is also well-suited for genotyping the large 5 
cohorts required for insightful study of population genetics and disease association, as well as 6 
donor selection for clinical transplantation. All components of the method were validated using 7 
panels of DNA samples that represent the observed range of human variation for these complex 8 
genomic regions. Both the method and the information we have obtained during its development 9 
should prove valuable resources for future studies.  10 
 11 
We used DNA from well-characterized immortalized human B cell lines as reference materials 12 
during the design and optimization of the laboratory and bioinformatics methods. These panels of 13 
IHWG and 1000 Genomes cell lines are generally available for other researchers (see Web 14 
Resources). For validation we focused on lineage II KIR genes, because they exhibit some of the 15 
most extreme and complex genomic variation within the human KIR locus. We identified and 16 
distinguished deletions and duplications of KIR3DL1/S1 and presence of the KIR3DL1/2v fusion 17 
gene, at the same time as defining the alleles of these genes. This was achieved by the combination 18 
of quantitative assessment of read depth and virtual sequence probing, coupled with reference 19 
alignment. Such independent verification is critical for characterizing structural KIR variants, 20 
which are not detected by methods that depend only on the alignment of sequence reads to 21 
reference haplotypes.64; 65 In summary, the validation experiments demonstrate our method to be 22 
robust and capable of detecting the full range of KIR genomic variation.  23 
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 1 
With few exceptions, studies of KIR in human populations and disease cohorts have analyzed KIR 2 
gene content, but not allelic diversity.66; 67 Such studies were seminal for showing how KIR 3 
genomic diversity can shape the immune response and provide resistance to disease.68 Gene 4 
content studies also uncovered the influence of KIR diversity on the success of reproduction and 5 
bone marrow transplantation.9; 11 The few studies that have focused on specific KIR genes, their 6 
allelic diversity and copy number, have refined these disease associations and implicated specific 7 
alleles.61; 69 In the course of validating our method, we identified and characterized 116 novel KIR 8 
alleles. This new knowledge of KIR polymorphism makes substantial contributions to the KIR 9 
database.15 For example, the number of KIR3DL2 alleles was doubled and is now in excess of 100. 10 
We also show that 476 (22.5%) of the 1000 Genomes individuals have at least one example of a 11 
structural variant or novel allele of KIR3DL1/S1 or KIR3DL2 (Figure S5c). All of these genomic 12 
variations have potential to influence NK cell function, but they are not visible to typing at the 13 
level of KIR gene content. A strong case can therefore be made that high-resolution knowledge of 14 
KIR diversity, in all its forms, will identify additional disease associations and improve the 15 
understanding of those already known.  16 
 17 
The study of human populations, their evolutionary dynamics, ancestry and disease, has benefited 18 
from methods of genome-wide associations (GWAS) that genotype numerous SNP markers in 19 
large cohorts of individuals. Such analysis of the KIR region has been impractical, because its 20 
extraordinary structural diversity leaves few locations suitable for designing binary SNP markers, 21 
and many of the KIR region genotyping results fail routine quality control filters. Thus the 22 
‘immunochip’, which focuses on immune-system genes70 and has refined the role of HLA-23 
31 
 
associated diseases, includes relatively few informative SNPs in the KIR region. These SNPs are 1 
located in the KIR3DL3, KIR2DL4, KIR3DL1/S1 and KIR3DL2 genes, which were previously 2 
assumed to be present in one copy on every haplotype.14 Our study demonstrates that this is not the 3 
reality. In more than 10% of the 1000 Genomes individuals, one of these four KIR genes is either 4 
deleted, duplicated or part of a fusion gene. We conclude that SNP genotyping within the KIR 5 
locus using standard binary measurement is of little practical value. 6 
 7 
To compensate for the absence of suitable SNPs within the KIR genes, an imputation method was 8 
recently described, which should give accurate re-assessment of KIR gene content diversity for 9 
many of the reported GWAS.28 Imputation of HLA class I alleles from GWAS data has been 10 
informative for studies of immune-mediated diseases.71 HLA allele imputation has varying 11 
efficiency, particularly in non-European individuals, in part because >10,000 alleles are described, 12 
but also because imputation relies on linkage disequilibrium, which can extend for shorter genomic 13 
tracts in non-Europeans than Europeans.15; 71 Many of the KIR variants and polymorphisms 14 
identified by our method are not evenly distributed across human populations. For example, the 15 
KIR3DL1/2v gene fusion is restricted to Africans, who exhibit the lowest linkage disequilibrium, 16 
worldwide. Thus, it is unlikely that imputation will be able to resolve all the structural and allelic 17 
diversity of KIR. 18 
 19 
We employed short-read technology because of its high fidelity. Pressing this point, all the novel 20 
SNPs identified by our method were confirmed by independent and well-established sequencing 21 
methods. The capture method we used, will probably soon be adapted to obtain longer fragment 22 
sizes and read lengths, which should become increasingly valuable as the sequencing error rates 23 
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decrease.72 Because we are able to capture and sequence the chimpanzee KIR region, we show the 1 
method we described likely captures the extent of human KIR diversity. Thus there is limited 2 
allelic dropout. Alternative methods that do not suffer allelic dropout are whole genome 3 
approaches. Because our method targets large numbers of individuals and with low impact on 4 
sequencing instrument and reagent resources, our assay provides an economic and practically 5 
viable alternative to whole-genome experiments. We also note our bioinformatics pipeline can 6 
obtain accurate KIR genotypes from any whole-genome sequencing experiments of sufficient mean 7 
depth. The pipeline is also designed for application to any highly polymorphic gene system. Our 8 
approach is aimed for genotyping very large numbers of individuals but with low impact on 9 
computer resources. In those properties it differs from the population graph method of allele 10 
designation that has been applied to HLA.73 However, this method could be a valuable complement 11 
to our methods if also applied to KIR. 12 
 13 
The first KIR cDNA sequences were reported in the late 1990s.74; 75 This led to research that 14 
revealed the unanticipated scope of genetic complexity and diversity of the human KIR gene 15 
family.27 The method we describe here will facilitate determination of a complete description of 16 
KIR variation in the human population, its interaction and co-evolution with HLA class I, and its 17 
influence on physiology, disease and immunotherapy.  18 
 19 
  20 
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Appendix A; KIR nomenclature 1 
Throughout this paper any unique DNA sequence that spans a coding region (otherwise known as 2 
coding DNA sequence; CDS) is considered a distinct allele. Those alleles that encode a unique 3 
protein sequence define an allotype. KIR genes and alleles are named by the KIR nomenclature 4 
committee, formed from members of the WHO Nomenclature Committee for factors of the HLA 5 
system, and members of the HUGO Genome Nomenclature Committee.15 The KIR database is part 6 
of the ImmunoPolymorphism database (IPD), which is listed in the Web Resources section.  7 
 8 
In the nomenclature for alleles, the digit (2 or 3) and letter D following the ‘KIR’ prefix indicate 9 
whether two (2D) or three (3D) immunoglobulin-like domains are present in the encoded protein. 10 
After the letter D is another letter, either L, S or P. The letters L and S refer to the relative length of 11 
the cytoplasmic tail: being either short (S) or long (L). Long-tailed KIR are inhibitory receptors, 12 
whereas short-tailed KIR are activating receptors. P denotes a pseudogene. Next is a number that 13 
distinguishes KIR encoded by different genes, but having the same domain number and signalling 14 
function. There are two instances where a pair of KIR gene names was combined to form one name 15 
after it became apparent they occupied the same locus –these are KIR2DL2/3 and KIR3DL1/S1. 16 
Following the gene name, there are three fields of numbers that distinguish the various types of 17 
alleles. The first field, of three digits, distinguishes alleles that encode different allotypes. Thus 18 
these alleles encode proteins with different amino-acid sequences. The second field, of two digits, 19 
distinguishes alleles that encode the same allotype, but differ by one or more synonymous 20 
substitutions in the coding region. The third field, also of two digits, distinguishes alleles with the 21 
same coding region sequence but have one or more substitutions in introns, flanking regions and 22 
other parts of the gene. For example, KIR3DL2 is a receptor with three Ig-like domains and 23 
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inhibitory signalling function. KIR3DL2*001 and KIR3DL2*002 are alleles that encode allotypes 1 
with different amino-acid sequence, whereas the KIR3DL2*00101 and KIR3DL2*00102 alleles 2 
both encode the KIR3DL2*001 allotype, but differ by a synonymous nucleotide substitution in the 3 
coding region sequence. The KIR3DL2*0010101 and KIR3DL2*0010102 alleles also encode the 4 
KIR3DL2*001 allotype, but they differ by nucleotide substitutions in the introns.  5 
 6 
There are four phylogenetically distinguished lineages of human KIR.76 Lineage I and III KIR 7 
molecules possess two Ig-like domains. Lineage I (KIR2DL4-5) interact with HLA ligands of low 8 
polymorphism including HLA-G, and lineage III (KIR2DL1-3, KIR2DS1-5) interact with specific 9 
allotypes of HLA-B and -C molecules. Lineage II (KIR3DL1/S1 and KIR3DL2) and V 10 
(KIR3DL3) molecules have three Ig-like domains. Lineage II molecules interact with allotypes of 11 
HLA-A or -B,77 and the ligand for lineage V remains unknown. We focused on the lineage II 12 
because this lineage is characterized by extensive structural and sequence diversity.13; 23 Although 13 
most human KIR haplotypes have two lineage II genes, KIR3DL1/S1 and KIR3DL2, some 14 
haplotypes have deleted KIR3DL1/S1, some have duplicated KIR3DL1/S1 and some have an in-15 
frame fusion of KIR3DL1 and KIR3DL2, termed KIR3DL1/2v.13 There are three divergent lineages 16 
of KIR3DL1/S1, the inhibitory KIR3DL1*005 and KIR3DL1*015, which are divergent and highly 17 
polymorphic, and activating KIR3DS1, which is less polymorphic.23 18 
 19 
KIR haplotypes form two groups: A and B. KIR A haplotypes have a fixed content of seven genes 20 
and two pseudogenes, whereas KIR B haplotypes vary in gene content.6; 14; 27 There are around 20 21 
common KIR B haplotypes with different gene content and numerous additional KIR B haplotypes 22 
that are rare6; 12; 27 23 
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 1 
HLA class I alleles are named using a hierarchical set of fields, separated by colons, and each 2 
containing as many different digits as is needed to distinguish all alleles. The first field 3 
distinguishes the major alleles, which differ by multiple nucleotide and amino-acid substitutions 4 
(e.g. HLA-A*01 and HLA-A*02). The second field distinguishes the subtypes of each major allele 5 
(e.g. HLA-A*02:01 and HLA-A*02:153), which encode allotypes that differ by one or more amino-6 
acid substitutions (e.g. HLA-A*02:01 and HLA-A*02:153). The third field distinguishes subtypes 7 
that encode proteins of identical amino-acid sequence, but differ by one or more synonymous 8 
substitutions within the protein-encoding exons (e.g. HLA-A*02:01:01 and HLA-A*02:01:02). The 9 
fourth field distinguishes subtypes that have identical coding-region sequence, but differ by one or 10 
more nucleotide substitutions within introns or the transcribed 3' and 5' flanking regions (e.g. HLA-11 
A*02:01:01:01 and HLA-A*02:01:01:02). In addition, suffix letters are used to denote known 12 
expression variants (e.g. N denotes a 'Null' allele, for which the encoded protein is not expressed at 13 
the cell surface). 14 
 15 
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Web Resources and Accession Numbers 1 
The URLs for data, material and programs used herein are as follows: 2 
Coriell repository, https://catalog.coriell.org/ 3 
FastX toolkit, http://hannonlab.cshl.edu/fastx_toolkit/ 4 
GenDX NGSengine, http://www.gendx.com/ 5 
Haplo.stats, http://www.mayo.edu/research/labs/statistical-genetics-genetic-epidemiology/ 6 
ImmunoPolymorphism database (IPD), http://www.ebi.ac.uk/ipd/ 7 
International Histocompatibility Working Group (IHWG), www.ihwg.org/ 8 
OMIM, http://www.omim.org/ 9 
PING scripts (The versions of PING components used to generate the data described here), 10 
https://web.stanford.edu/~n0rmski/projectH/ 11 
PING executable R files (The latest versions of PING_gc and PINGallele), 12 
https://github.com/wesleymarin/ 13 
R program, https://www.r-project.org/ 14 
 15 
Newly-discovered KIR and HLA class I allele sequences were submitted to GenBank and the IPD 16 
database.15 Their official names and GenBank accession numbers are given below and in Figure S6 17 
(KIR prefix excluded for brevity): 18 
3DL1*00103 (LN606766), 3DL1*00104 (KP784298), 3DL1*00105 (KP784297), 3DL1*00404 19 
(KP784290), 3DL1*00504 (KP784291), 3DL1*00505 (KP784294), 3DL1*01506 (KP784293), 20 
3DL1*05902 (KP784300), 3DL1*077 (LN606765), 3DL1*088 (LN606767), 3DL1*089 21 
(LN606768), 3DL1*090 (LN606769), 3DL1*091 (LN606770), 3DL1*092 (LN606771), 22 
3DL1*093 (LN606772), 3DL1*094N (LN606773), 3DL1*095 (KP784289), 3DL1*096 23 
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(KP784285), 3DL1*097 (KP784286), 3DL1*098 (KP784301), 3DL1*099 (KP784288), 3DL1*100 1 
(KP784299), 3DL1*101 (KP784292), 3DL1*102 (KP784295), 3DL1*103 (KP784296), 3DL1*109 2 
(KP784287), 3DS1*01304 (KP784279), 3DS1*01305 (KP784278), 3DS1*01306 (KP784276), 3 
3DS1*01307 (KP784284), 3DS1*104 (KP784277), 3DS1*105 (KP784280), 3DS1*106 4 
(KP784283), 3DS1*107 (KP784281), 3DS1*108 (KP784282), 3DL2*00106 (KJ535483), 5 
3DL2*081 (KJ535484), 3DL2*073 (KJ535485), 3DL2*071 (KJ535486), 3DL2*080 (KJ535487), 6 
3DL2*00303 (KJ535488), 3DL2*00703 (KJ535489), 3DL2*069 (KJ535490), 3DL2*070 7 
(KJ535491), 3DL2*072 (KJ535492), 3DL2*074 (KJ535493), 3DL2*068 (KJ535494), 8 
3DL2*00304 (KJ535495), 3DL2*079 (KJ535496), 3DL2*077 (KJ535497), 3DL2*01002 9 
(KJ535498), 3DL2*076 (KJ535500), 3DL2*00203 (KJ535501), 3DL2*082 (KJ535502), 10 
3DL2*078 (KJ535503), 3DL2*101 (LN995832), 3DL2*00708 (LN995833), 3DL2*100 11 
(KP784305), 3DL2*102 (LN995834), 3DL2*00705 (LN649139), 3DL2*089 (LN649146), 12 
3DL2*00502 (LN649136), 3DL2*095 (LN649155), 3DL2*00204 (LN649156), 3DL2*00706 13 
(LN649150), 3DL2*084 (LN649140), 3DL2*093 (LN649152), 3DL2*087 (LN649143), 14 
3DL2*00707 (LN649153), 3DL2*098 (KP784302), 3DL2*094 (LN649154), 3DL2*01003 15 
(LN649149), 3DL2*00107 (LN649144), 3DL2*085 (LN649141), 3DL2*086 (LN649142), 16 
3DL2*088 (LN649145), 3DL2*090 (LN649147), 3DL2*097 (KP784303), 3DL2*091 17 
(LN649148), 3DL2*096 (LN649157), 3DL2*092 (LN649151), 3DL2*00704 (LN606764), 18 
3DL2*01004 (KP784304), 3DP1*01002 (KP893537), 3DP1*015 (KP893538), 3DL2*108 19 
(LN999781), 3DL2*107 (LN999782), 3DL2*104 (LN999783), 3DL2*109 (LN999784), 20 
3DL2*00602 (LN999785), 3DL2*106 (LN999786), 3DL2*04302 (LN999787), 3DL2*00709 21 
(LN999788), 3DL2*01004 (LN999790), 3DL2*103 (LN999791), 3DL2*01902 (LN999792), 22 
3DL2*021 (LN999793), 3DL2*07902 (LN999794), 3DL2*06002 (LN999795), 3DL2*105 23 
38 
 
(LN999796), 3DL2*00109 (LN999797), 3DL2*10002 (LN999798), 2DL1*032N (KP893536), 1 
2DL3*034 (KP784272), 2DL5A*021 (KP784273), 2DP1*00203 (KP784307), 2DP1*00204 2 
(KP784309), 2DP1*015 (KP784306), 2DP1*016 (KP784275), 2DP1*017 (KP784308), 3 
2DP1*018 (KP784274), 2DP1*019 (KP784310), 2DS3*008 (KP784269), 2DS5*015 (KP784270), 4 
2DS5*016 (KP784271), HLA-C*01:02:30 (KP893072), HLA-C*07:18 (KP893073).  5 
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Figure Titles and Legends 1 
Figure 1. Pipeline for analyzing sequence data from highly-polymorphic and structurally 2 
divergent haplotypes (KIR). 3 
A. The PING (Pushing Immunogenetics to the Next Generation) pipeline has two broad arms and 4 
two modules. The first module (PING_gc) determines KIR gene copy numbers, and the second 5 
module (PING_allele) determines their alleles. Within each module are two arms. The first arm 6 
(KFFgc and KFFallele) is an analysis independent of any alignment or assembly that uses virtual 7 
probes to mine the raw data, and the second arm (MIRAgc and SOS) performs filtering and 8 
alignment of reads to reference sequences. Thus both copy-number and allele genotype are each 9 
derived by two independent methods. The techniques are described fully in the Methods. 10 
 11 
B. Lists the data generated using the method described herein (1-3), and those obtained from other 12 
sources (4). Shown are the number of individuals, the genotyping results that they are used to 13 
validate, and the independent laboratory method used for this purpose is given at the far right. 14 
 15 
Figure 2. KIR gene copy number genotype determined by read depth. 16 
Shows that the ratio of reads mapping to a specific KIR gene relative to those that map to 17 
KIR3DL3 can be used to calculate KIR copy number. The results from 97 samples are shown and 18 
sorted by the ratio. KIR2DL4 (left) was present in 1, 2 or 3 copies per individual in the sample set 19 
and KIR2DL5 (right) as 0, 1, 2, 3 or 4 copies.  20 
 21 
Figure 3. The KIR region is >99.99% covered by the sequence data 22 
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A. Shows the target KIR region of chromosome 19: the gene locations are shown in orange and 1 
pseudogenes in gray. The KIR region varies in gene content and shown are two frequent ‘A’ and 2 
‘B’ haplotypes. The ‘KIR’ prefix is omitted from the gene names for clarity (See Appendix A: KIR 3 
and HLA nomenclature). The human reference build hg19 has a KIR A haplotype. Underneath is a 4 
KIR B haplotype shown to scale. 5 
  6 
B. Shows the read depth following stringent alignment of sequence reads (no base pairs mismatch 7 
and duplicates removed) from the PGF cell line to the PGF reference KIR haplotypes 1 (light 8 
purple) and 2 (dark purple). 9 
 10 
C. Coordinates and features of two short gaps in PGF KIR haplotype 2. At the right is shown the 11 
location of the gaps. 12 
 13 
Figure 4. KIR gene content and copy number genotypes 14 
A. Gene content genotypes derived from all 97 cell lines using the PING pipeline. Black box 15 
indicates gene is present and clear box indicates absence. One example from each observed gene 16 
content genotype (GC type) is shown, with the number observed shown at the right. 17 
 18 
B. Independent validation of the KIR copy number genotypes by real-time PCR12 on 85 samples. 19 
There were four discrepancies due to alleles undetected by real-time PCR (allele). There were two 20 
false positives (pos) and two false negatives (neg), by real-time PCR. Two discrepancies remain 21 
unexplained. 22 
 23 
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C. Gene copy number genotypes derived from all 97 cell lines using PING_gc. Colored rectangle 1 
indicates gene present, and the shades represent the copy number as indicated in the key. One 2 
example from each observed gene copy number genotype (CN type) is shown, with the number 3 
observed at the right.  4 
 5 
Figure 5. High resolution allele-level genotyping of KIR 6 
Four examples of high-resolution allele and copy-number genotypes of lineage II KIR and their 7 
segregation in family trios: C - child, F -father, M - mother. Colored boxes show the segregating 8 
alleles. All members of family 1 have two alleles each of KIR3DL1/S1 and KIR3DL2. Family 2 9 
shows segregation of the KIR3DL1/2v fusion gene (the allele named KIR3DL1*059) that consists 10 
of exons 1-6 from KIR3DL1 and 7-9 from KIR3DL2.13; 78 For clarity KIR3DL1/2v is shown as an 11 
allele of KIR3DL1, and so there is no allele of KIR3DL2 on this haplotype. Family 3 shows 12 
segregation of a haplotype that lacks KIR3DL1/S1 and marked by presence of KIR3DL2*006. The 13 
gene copy numbers were determined using PING_gc, which indicated one copy of KIR3DL1 was 14 
present in each of individuals 3C and 3M and two copies in 3F. Family 4 shows both the 15 
KIR3DL1/2v and the KIR3DL1 negative haplotypes segregating to the child.  16 
 17 
Figure 6. High resolution KIR allele and copy number genotypes of 97 IHWG cells 18 
Shows four examples of high-resolution allele and copy-number genotypes of KIR. Individual 1 19 
(SP0010) is homozygous KIR-A haplotype. Individual 2 (CB6B) has two different B haplotypes. 20 
Individual 3 (E481324) has duplication of three loci (in blue shading: denoted as 3DP1b, 2DL4b, 21 
3DL1/S1b). Individual 4 (LZL) has deletion of the central segment of the KIR haplotype (red). 22 
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Yellow shading denotes alleles that were identified for the first time in the current study. The full 1 
genotypes for each IHWG cell are given in Figure S7. 2 
 3 
Figure 7. Capture of HLA class I genes for high-resolution allele genotyping 4 
A. Shown is the read depth across each of the HLA class I genes from a representative sample 5 
(chosen virtue of having closest to the mean number of HLA-specific reads). Green lines indicate 6 
the coordinates of the exons that were covered. To generate this figure, full gene sequences (~3kb 7 
each) were obtained from IPD to represent all of the five HLA class I alleles known to be present 8 
in this sample (the sample is homozygous for a common allele of HLA-A). Sequence reads were 9 
filtered to be specific for HLA-A, -B -C, then aligned to these references with high stringency. The 10 
read depth was measured using Samtools/bcf. 11 
 12 
B. Lists the major HLA class I allele types detected in the study. 13 
 14 
